Roles for aberrant CXCR3 signaling in basal cell carcinoma: a case for dual activity.
Yu
Yanlin
Y
Laboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4264, USA. YuY@mail.nih.gov
Merlino
Glenn
G
D000818:Animals; D002280:Basal Cell Carcinoma / Q000378:metabolism*; D049109:Cell Proliferation; D002470:Cell Survival; D018450:Disease Progression; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D051379:Mice; D054367:Receptors, CXCR3 / Q000378:metabolism*; D015398:Signal Transduction; D012878:Skin Neoplasms / Q000378:metabolism*
C515187:CXCR3 protein, human; D054367:Receptors, CXCR3